FinalDose is a startup based in the United Kingdom, 1 tracked investor.
Based in the United Kingdom, FinalDose is a startup. Brouky records 1 investor associated with the company.
FinalDose is developing a programmable therapeutic molecule that recognizes disease-associated DNA sequences and selectively kills the matching cells. The company is initially focused on applying this DNA-recognition approach to oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.